<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="179856">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00753441</url>
  </required_header>
  <id_info>
    <org_study_id>NNR-02</org_study_id>
    <nct_id>NCT00753441</nct_id>
  </id_info>
  <brief_title>Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head</brief_title>
  <acronym>STENTBY</acronym>
  <official_title>Endoscopic Biliary Stenting on Demand Versus Surgical Biliary Bypass for Palliation of Patients With Advanced Cancer of the Pancreatic Head: STENTBY - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prognosis of patients with unresectable pancreatic cancer is dismal. Hence, palliation
      of tumor-associated symptoms, in particular jaundice due to low bile duct obstruction and
      gastric outlet obstruction, is the primary aim of these patients' care. Endoscopic stenting
      and surgical bypass are currently the two competing treatment options. There is currently no
      randomized trial comparing the recently developed metal stents to surgical bypass.
      Furthermore, there is very limited data on quality of life of these patients receiving
      either therapy. While endoscopic stenting represents the less invasive treatment, surgery
      may provide better long-term control requiring one-time treatment. Due to the incomplete
      evidence the present randomized controlled trial is designed to compare quality of life of
      patients undergoing endoscopic stenting on demand or surgical bypass for palliation of
      symptoms caused by cancer of the pancreatic head requiring with low bile duct obstruction.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2008</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum bilirubin</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure-related complications</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgical bypass (choledochojejunostomy, in combination with gastroenterostomy if necessary)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endoscopic biliary stenting using metal stent (completed by duodenal stent, if necessary)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgical bypass</intervention_name>
    <description>Surgical bypass (choledochojejunostomy, in combination with gastroenterostomy if necessary)</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic stenting</intervention_name>
    <description>Placement of a biliary metal stent (in combination with a duodenal metal stent in case of gastric outlet obstruction if necessary)</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age equal or greater than 18 years

          -  Diagnosis of unresectable cancer of the pancreatic head (after clinical, laboratory,
             radiological assessment) requiring palliative treatment for biliary obstruction. In
             unclear cases an exploratory laparotomy will be performed and resectability will be
             evaluated intraoperatively

          -  Operability certified by anesthesiologist

          -  Written informed consent

        Exclusion Criteria:

          -  Intervention technically/medically not feasible

          -  Expected lack of compliance

          -  One treatment option considered to be clearly in favor of the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno Schmied, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of General, Visceral and Transplantation Surgery, University of Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nuh N Rahbari, MD</last_name>
    <phone>+49 6221 56</phone>
    <phone_ext>39448</phone_ext>
    <email>nuh.rahbari@med.uni-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bruno Schmied, MD</last_name>
    <phone>+49 6221 56</phone>
    <phone_ext>36540</phone_ext>
    <email>bruno.schmied@med.uni-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universityhospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuh N Rahbari, MD</last_name>
      <phone>+49 6221 56</phone>
      <phone_ext>39448</phone_ext>
      <email>nuh.rahbari@med.uni-heidelberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Bruno Schmied, MD</last_name>
      <phone>+49 6221 56</phone>
      <phone_ext>36540</phone_ext>
      <email>bruno.schmied@med.uni-heidelberg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Bruno Schmied, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 20, 2013</lastchanged_date>
  <firstreceived_date>September 15, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Heidelberg</investigator_affiliation>
    <investigator_full_name>Nuh Rahbari</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Pancreatic cancer</keyword>
  <keyword>Bile duct obstruction</keyword>
  <keyword>Stent</keyword>
  <keyword>Bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Cholestasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
